Return to flip book view

BEYOND COVID April 20, 202211:00 am - 1:00pmL E S S O N S L E A R N E DHealthcare Innovation Symposium XXXVII

11:00-11:05 am11:05-11:30 am11:30-11:45 am11:45 am-12:00 pmWELCOME AND INTRODUCTIONSPANELIST PRESENTATIONSOVERVIEW AND LESSONS IN PUBLIC POLICYMark McClellan, MD, PhDDirector, Duke-Margolis Center for Health Policy, Duke UniversityFormer Commissioner of the U.S. Food and Drug Administration (FDA)Former Administrator of the Centers for Medicare & Medicaid Services (CMS)Fred Sanfilippo, MD, PhDDirector, Emory-Georgia Tech Healthcare Innovation ProgramProfessor of Pathology & Laboratory Medicine, Emory University School of MedicineProfessor of Health Policy & Management, Rollins School of Public Health LESSONS IN RESEARCH AND TECHNOLOGY DEVELOPMENTRavi Bellamknoda, PhDProvost and Executive Vice President for Academic AffairsEmory UniversityProgramKEYNOTE SPEAKERLESSONS IN HEALTH DISPARATIESJoseph A. Tyndall, MD, MPHExecutive Vice President for Health Affairs Dean & ProfessorMorehouse School of MedicineLESSONS IN HEALTH PROFESSIONS EDUCATIONSanjay Desai, MDChief Academic Officer and Group Vice President of Medical Education American Medical Association (AMA)LESSONS IN PROVIDING CLINICAL CARESharon Pappas, PhD, RN, FAANChief Nurse ExecutiveEmory Healthcare12:00-12:15 pm12:15-12:30 pmLESSONS IN PUBLIC HEALTH AND COMMUNICATIONSCarlos del Rio, MDExecutive Associate Dean for Emory at Grady12:30-12:45 pmQ&A WITH PANELISTS12:45-1:00 pm

Mark McClellan, MD, PhDDirector, Margolis Center for Health PolicyProfessor of Business, Medicine and Health Policy Duke UniversityMark B. McClellan, MD, PhD, is a doctorand an economist whose work hasaddressed a wide range of strategies andpolicy reforms to improve health care,including payment reforms to promotebetter outcomes and lower costs,methods for development and use of real-world evidence and approaches for moreeffective drug and device innovation.McClellan is a former administrator of theCenters for Medicare & Medicaid Services(CMS) and former commissioner of the USFood and Drug Administration (FDA),where he developed and implementedmajor reforms in health policy. McClellanhas served as a member of thePresident’s Council of Economic Advisorsand as deputy assistant secretary of theTreasury for Economic Policy. He was alsoa Senior Fellow at the BrookingsInstitution and a professor of economicsand medicine at Stanford Universitywhere he directed the Program on HealthOutcomes Research.

Ravi Bellamkonda, PhDProvost and Executive Vice President for Academic AffairsEmory UniversityRavi V. Bellamkonda serves as Emory’sprovost and executive vice president foracademic affairs. He is the chief academicofficer of Emory University and isresponsible for ensuring the quality ofundergraduate, graduate, and professionaleducation and enhancing Emory’s role asan eminent research university throughexcellence in faculty research, teaching,and scholarship. Bellamkonda collaborates with membersof the Provost Leadership Team and otheruniversity leaders to formulate academicpriorities and policy, allocate resourcesappropriately, and oversee the facultypromotion-and-tenure process withassistance from the Tenure and PromotionAdvisory Committee. He serves as chair ofthe Council of Deans, which comprises theleaders of Emory’s nine schools and theEmory Libraries, and as chair of the Waysand Means Committee, which leads thepreparation of the university’s annualunrestricted operating budget. Prior to becoming provost at Emory,Bellamkonda served as dean of the PrattSchool of Engineering at Duke University.Previously, he was Wallace H. CoulterProfessor and chair of the Department of Biomedical Engineering at GeorgiaInstitute of Technology and EmoryUniversity. A trained bioengineer andneuroscientist, Bellamkonda holdsan undergraduate degree inbiomedical engineering. Hisgraduate training at BrownUniversity was in biomaterials andmedical science (with PatrickAebischer), and his postdoctoraltraining at Massachusetts Instituteof Technology focused on themolecular mechanisms of axonguidance and neural development(with Jerry Schneider and SonalJhaveri).

Ravi Bellamkonda, PhD (cont.)Provost and Executive Vice President for Academic AffairsEmory UniversityBellamkonda is committed to fosteringtransformative research and pedagogicalinnovation as well as programs that createan entrepreneurial mindset among facultyand students. His current researchexplores the interplay of biomaterials andthe nervous system for neural interfaces,nerve repair, and brain tumor therapy. From 2014 to 2016, Bellamkonda servedas president of the American Institute forBiological and Medical Engineering, theleading policy and advocacy organizationfor biomedical engineers, withrepresentation from industry, academia,and government. Bellamkonda’snumerous awards include the ClemsonAward for Applied Research from theSociety for Biomaterials, EUREKA awardfrom the National Cancer Institute(National Institutes of Health), CAREERaward from the National ScienceFoundation, Lifetime Achievement Awardfrom Ian’s Friends Foundation supportingPediatric Brain Tumor Research, and BestProfessor Award from the Georgia TechBiomedical Engineering student body.

Joseph (Adrian) Tyndall, MD, MPHExecutive Vice President for Health Affairs Dean & ProfessorMorehouse School of MedicineDr. Joseph (Adrian) Tyndall, M.D., M.P.H., isthe Executive Vice President for HealthAffairs and Professor and Dean of theMorehouse School of Medicine. Prior toMorehouse School of Medicine, Dr.Tyndall served as a professor and Chair ofthe Department of emergency medicineat the University of Florida College ofMedicine for more than a decade andalso held positions of interim dean of theCollege of Medicine as well as AssociateVice President for Strategic and AcademicAffairs for UF Health in Gainesville Florida. Dr. Tyndall is a graduate of the Universityof Maryland School of Medicine and theemergency medicine residency programat the University of Maryland MedicalSystem. In addition, he received hismaster’s degree in Health ServicesManagement and Health Policy fromColumbia University in the City of NewYork. He served on the Board of Directorsof UF Health Shands Hospital at theUniversity of Florida for a decade and waschair of the Board of Trustees for the UFHealth Proton Therapy Institute during histenure as interim dean for almost threeyears. He is also a past president of theFlorida College of Emergency Physicians.He is currently a member of the Board of Directors of Grady Health Systemin Atlanta Georgia, is a trusteeand president-elect of theSociety for Academic EmergencyMedicine Foundation -emergencymedicine’s national foundationsupporting education andresearch in emergency care. Heis an elected member of theAlpha Omega Alpha HonorSociety and the Gold HumanismHonor Society. He has publishedand lectured extensivelynationally and internationally inemergency medicine and hasactive research interests in acutebrain injury.

Sanjay Desai, MSChief Academic OfficerGroup Vice President of Medical Education American Medical Association (AMA)Sanjay Desai, M.D., is the Chief AcademicOfficer and Group Vice President ofMedical Education. Dr. Desai joined theAMA after serving most recently as MyronL. Weisfeldt Professor of Medicine, Directorof the Osler Medical Residency, and ViceChair for Education at Johns HopkinsUniversity School of Medicine. In theseroles, Dr. Desai led the development ofinnovative programs, curricula, andresearch aimed at improving medicalstudent and resident well-being, ensuringphysicians-in-training are better preparedto navigate health systems, and enrollingmore medical trainees from groupsunderrepresented in medicine. In addition to serving for more than adecade in a variety of medical educationroles at Johns Hopkins University, Dr. Desaisimultaneously cared for patients as anattending physician in the medical ICU atthe Johns Hopkins Hospital—most recentlyduring the COVID-19 pandemic. Prior to his work at Johns Hopkins, Dr.Desai served as Associate ProgramDirector for both the Internal MedicineResidency Program and the Pulmonary andCritical Care Medicine Fellowship atGeorgetown University WashingtonHospital Center.Dr. Desai also served as a managementconsultant for several years before andduring his medical training, anexperience that helped him create afellowship in health systemsmanagement, and a new medicalstudent curriculum while at JohnsHopkins. The curriculum forms“consulting teams” of students who aretasked with solving problems across thehealth system.Dr. Desai earned both a B.S. inbioengineering and economics from theUniversity of Pennsylvania and earnedhis M.D. from Harvard Medical School.Dr. Desai completed his residency, chiefyear, and a fellowship in pulmonary andcritical care medicine at the JohnsHopkins Hospital.

Dr. Pappas oversees nursing practice forEmory Healthcare's 11 hospitals andambulatory sites and serves as amember of the senior leadership teamat Woodruff Health Science Center.Under her leadership, four of thesystem's hospitals have achievedMagnet designation or re-designation. Dr. Pappas's research focus is on clinicaland financial outcomes related tonursing. She served on the NationalAcademy of Medicine’s consensus studycommittee on clinician well-being and iscurrently a member of the Commissionon Magnet. Sharon H. Pappas, PhD, RN, FAANChief Nurse ExecutiveEmory Healthcare

Carlos del Rio, MD is a DistinguishedProfessor of Medicine in the Division ofInfectious Diseases at Emory UniversitySchool of Medicine. He is also ExecutiveAssociate Dean for Emory at Grady, PI andco-Director of the Emory Center for AIDSResearch (CFAR) and co-PI of the Emory-CDCHIV Clinical Trials Unit and the EmoryVaccine Treatment and Evaluation Unit. Dr.del Rio is a native of Mexico where heattended medical school at Universidad LaSalle, graduating in 1983. He did his InternalMedicine and Infectious Diseasesresidencies at Emory University. In 1989 hereturned to Mexico where he was ExecutiveDirector of the National AIDS Council ofMexico (CONASIDA, the Federal agency ofthe Mexican Government responsible forAIDS Policy throughout Mexico), from 1992through 1996. In November of 1996 hereturned to Emory where he has beeninvolved in teaching and research. Dr. delRio was Chief of the Emory Medical Serviceat Grady Memorial Hospital from 2001-2009and Chair of the Hubert Department ofGlobal Health from 2009-2019. His researchinterests include the epidemiology ofopportunistic infections in HIV and otherimmune deficiencies the epidemiology andtransmission dynamics of HIV and othersexually transmitted diseases and issuesrelated to early diagnosis of HIV, access tocare and compliance with antiretrovirals. Dr. del Rio is a Member of the ScientificAdvisory Committee of the Latin-AmericanAIDS Initiative (SIDALAC), Member of the Carlos del Rio, MDExecutive Associate Dean for Emory at GradyDistinguished Professor of MedicineEmory University School of MedicineMonitoring of the AIDS Pandemic(MAP) Network, Member of theBoard of the IAS-USA, member ofthe UNAIDS Scientific TechnicalAdvisory Committee and Chair of thePEPFAR Scientific Advisory Board. Heis Associate Editor for ClinicalInfectious Diseases and SeniorEditor for HIV for NEJM JournalWatch Infectious Diseases as well asan editorial board member of GlobalPublic Health, Journal of AIDS andWomen, Children & HIV. He has co-authored 5 books, 30 bookchapters, and over 450 scientificpapers.

Fred Sanfilippo, MD, PhD directs the Emory-Georgia Tech Healthcare Innovation Program,which has a mission to accelerate innovationin healthcare delivery science research,education, and service. He also serves asProfessor of Pathology and LaboratoryMedicine and Health Policy and Managementat Emory, and former Medical Director of theMarcus Foundation. For over 30 years he has been an academicleader at Duke, Johns Hopkins, Ohio State andEmory; serving as a division chief, departmentchair, program/center director, dean, medicalcenter CEO, university senior/executive VP,health system board chair and academichealth center CEO. During that time he hasled organizational and cultural changesyielding improved academic, clinical, andfinancial performance at each institution. Healso led the creation of the US ScientificRegistry of Transplant Recipients; JohnsHopkins Medical Labs; a personalized healthplan (YP4H) at OSU; and novel departmentsand centers in areas ranging from BiomedicalInformatics to Personalized Health andIntegrative Medicine. Sanfilippo received his BA and MS in physicsfrom the University of Pennsylvania, and hisMD and PhD in immunology from Duke,where he also did his residency training,receiving board certification in Anatomic &Clinical Pathology, and Immunopathology. Fred Sanfilippo, MD, PhDEmory-Georgia Tech Healthcare Innovation ProgramEmory UniversityHe has mentored more than 30 graduate student and fellows, servedon 13 editorial boards, publishedover 250 articles, received threepatents, and been awarded over $30million in sponsored research. He hasbeen board chair of five non-profits,and president of seven academic andprofessional organizations includingthe American Society of InvestigativePathology and the American Societyof Transplantation.

FOLLOW US ON SOCIALMEDIATweet your thoughts during thesymposium!@HIP_Emory #HIPSymposiumKeep up with our latest stories onInstagram!@hip_emory